Your Health, We Care
Used to treat adult patients with moderate to severe rheumatoid arthritis (RA) who have insufficient or intolerant response to one or more disease modifying antirheumatic drugs (DMARD). In terms of medication, filgotinib can be used as a monotherapy or in combination with methotrexate (MTX).
from FDA，2023.07
LuciusVersionofFilgotinib:DosageandAdministration,Indications,PrecautionsIndicationsRheumatoid Arthr···【more】
Recommended：542025-10-12
Used for relapsed/refractory mantle cell lymphoma and other B-cell malignancies.【more】
Article source：Lucius LaosRelease date：2026-01-05Recommended：5
Adult patients with moderate to severe rheumatoid arthritis (RA) who have insufficient or intolerant response to various disease modifying antirheumatic drugs (DMARD).【more】
Article source：Lucius LaosRelease date：2026-01-05Recommended：5
LuciusVersionofFilgotinib:DosageandAdministration,Indications,PrecautionsIndicationsRheumatoid ArthritisLuciFilgo is indicated for the treatment of adult patients with moderately t···【more】
Article source：Lucius LaosRelease date：2025-12-10Recommended：54
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
